Global Biosimilar Drug Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Biosimilar Drug Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

According to APO Research, The global Biosimilar Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Biosimilar Drug include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech and Innovent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biosimilar Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Biosimilar Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Biosimilar Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biosimilar Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Biosimilar Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Biosimilar Drug sales, projected growth trends, production technology, application and end-user industry.

Biosimilar Drug segment by Company

CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent
Biosimilar Drug segment by Type

Injection
Tablets
Other Types
Biosimilar Drug segment by Application

Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
Biosimilar Drug segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimilar Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biosimilar Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimilar Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biosimilar Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilar Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Biosimilar Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Biosimilar Drug Market Size, 2019 VS 2023 VS 2030
1.3 Global Biosimilar Drug Market Size Estimates and Forecasts (2019-2030)
1.4 Global Biosimilar Drug Sales Estimates and Forecasts (2019-2030)
1.5 Global Biosimilar Drug Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Biosimilar Drug Market Dynamics
2.1 Biosimilar Drug Industry Trends
2.2 Biosimilar Drug Industry Drivers
2.3 Biosimilar Drug Industry Opportunities and Challenges
2.4 Biosimilar Drug Industry Restraints
3 Biosimilar Drug Market by Manufacturers
3.1 Global Biosimilar Drug Revenue by Manufacturers (2019-2024)
3.2 Global Biosimilar Drug Sales by Manufacturers (2019-2024)
3.3 Global Biosimilar Drug Average Sales Price by Manufacturers (2019-2024)
3.4 Global Biosimilar Drug Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Biosimilar Drug Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Biosimilar Drug Manufacturers, Product Type & Application
3.7 Global Biosimilar Drug Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Biosimilar Drug Market CR5 and HHI
3.8.2 Global Top 5 and 10 Biosimilar Drug Players Market Share by Revenue in 2023
3.8.3 2023 Biosimilar Drug Tier 1, Tier 2, and Tier 3
4 Biosimilar Drug Market by Type
4.1 Biosimilar Drug Type Introduction
4.1.1 Injection
4.1.2 Tablets
4.1.3 Other Types
4.2 Global Biosimilar Drug Sales by Type
4.2.1 Global Biosimilar Drug Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Biosimilar Drug Sales by Type (2019-2030)
4.2.3 Global Biosimilar Drug Sales Market Share by Type (2019-2030)
4.3 Global Biosimilar Drug Revenue by Type
4.3.1 Global Biosimilar Drug Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Biosimilar Drug Revenue by Type (2019-2030)
4.3.3 Global Biosimilar Drug Revenue Market Share by Type (2019-2030)
5 Biosimilar Drug Market by Application
5.1 Biosimilar Drug Application Introduction
5.1.1 Ankylosing Spondylitis
5.1.2 Tumor
5.1.3 Rheumatoid Arthrtis
5.1.4 Cardiovascular
5.1.5 Other Application
5.2 Global Biosimilar Drug Sales by Application
5.2.1 Global Biosimilar Drug Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Biosimilar Drug Sales by Application (2019-2030)
5.2.3 Global Biosimilar Drug Sales Market Share by Application (2019-2030)
5.3 Global Biosimilar Drug Revenue by Application
5.3.1 Global Biosimilar Drug Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Biosimilar Drug Revenue by Application (2019-2030)
5.3.3 Global Biosimilar Drug Revenue Market Share by Application (2019-2030)
6 Global Biosimilar Drug Sales by Region
6.1 Global Biosimilar Drug Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Biosimilar Drug Sales by Region (2019-2030)
6.2.1 Global Biosimilar Drug Sales by Region (2019-2024)
6.2.2 Global Biosimilar Drug Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Biosimilar Drug Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Biosimilar Drug Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Biosimilar Drug Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Biosimilar Drug Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Biosimilar Drug Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Biosimilar Drug Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Biosimilar Drug Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Biosimilar Drug Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Biosimilar Drug Revenue by Region
7.1 Global Biosimilar Drug Revenue by Region
7.1.1 Global Biosimilar Drug Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Biosimilar Drug Revenue by Region (2019-2024)
7.1.3 Global Biosimilar Drug Revenue by Region (2025-2030)
7.1.4 Global Biosimilar Drug Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Biosimilar Drug Revenue (2019-2030)
7.2.2 North America Biosimilar Drug Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Biosimilar Drug Revenue (2019-2030)
7.3.2 Europe Biosimilar Drug Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Biosimilar Drug Revenue (2019-2030)
7.4.2 Asia-Pacific Biosimilar Drug Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Biosimilar Drug Revenue (2019-2030)
7.5.2 LAMEA Biosimilar Drug Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 CP Guojian Pharma
8.1.1 CP Guojian Pharma Comapny Information
8.1.2 CP Guojian Pharma Business Overview
8.1.3 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 CP Guojian Pharma Biosimilar Drug Product Portfolio
8.1.5 CP Guojian Pharma Recent Developments
8.2 Biotech Pharma
8.2.1 Biotech Pharma Comapny Information
8.2.2 Biotech Pharma Business Overview
8.2.3 Biotech Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Biotech Pharma Biosimilar Drug Product Portfolio
8.2.5 Biotech Pharma Recent Developments
8.3 Celgen Pharma
8.3.1 Celgen Pharma Comapny Information
8.3.2 Celgen Pharma Business Overview
8.3.3 Celgen Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Celgen Pharma Biosimilar Drug Product Portfolio
8.3.5 Celgen Pharma Recent Developments
8.4 Henlius
8.4.1 Henlius Comapny Information
8.4.2 Henlius Business Overview
8.4.3 Henlius Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Henlius Biosimilar Drug Product Portfolio
8.4.5 Henlius Recent Developments
8.5 Amgen
8.5.1 Amgen Comapny Information
8.5.2 Amgen Business Overview
8.5.3 Amgen Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Amgen Biosimilar Drug Product Portfolio
8.5.5 Amgen Recent Developments
8.6 Eli Lilly
8.6.1 Eli Lilly Comapny Information
8.6.2 Eli Lilly Business Overview
8.6.3 Eli Lilly Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Eli Lilly Biosimilar Drug Product Portfolio
8.6.5 Eli Lilly Recent Developments
8.7 Sandoz
8.7.1 Sandoz Comapny Information
8.7.2 Sandoz Business Overview
8.7.3 Sandoz Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Sandoz Biosimilar Drug Product Portfolio
8.7.5 Sandoz Recent Developments
8.8 Changchun High Tech
8.8.1 Changchun High Tech Comapny Information
8.8.2 Changchun High Tech Business Overview
8.8.3 Changchun High Tech Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Changchun High Tech Biosimilar Drug Product Portfolio
8.8.5 Changchun High Tech Recent Developments
8.9 Innovent
8.9.1 Innovent Comapny Information
8.9.2 Innovent Business Overview
8.9.3 Innovent Biosimilar Drug Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Innovent Biosimilar Drug Product Portfolio
8.9.5 Innovent Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Biosimilar Drug Value Chain Analysis
9.1.1 Biosimilar Drug Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Biosimilar Drug Production Mode & Process
9.2 Biosimilar Drug Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Biosimilar Drug Distributors
9.2.3 Biosimilar Drug Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings